5月18日，知社發布獨家新聞，披露美國打壓中國學者事態升級，Emory大學杰出講席教授實驗室突遭關閉，夫人也遭受牽連，在海內外引起廣泛關注。因官方新聞尚未發布，知社為保護當事人，選擇隱藏學校和姓名信息。隨后國內多家網絡媒體跟進，包括BioWorld，材料科學與工程，賽先生，知識分子等，都做了轉播和進一步報道，而且點出了Emory大學李曉江和李世華兩位教授的名字。

美東時間5月23日，Emory大學對知社報道作出回應，發布公開聲明如下，其核心是NIH高度關注海外勢力對美國科研的影響，調查發現兩位教員沒有完全披露其海外研究經費來源及其在中國高校和研究所的工作范圍。Emory就此向NIH做了匯報，而這兩位教授也已不再受雇于Emory。也就是說，被解職了：

“The National Institutes of Health (NIH) and other federal funding agencies have raised concerns regarding foreign influence on research activities in the United States, as expressed in NIH Director Dr. Francis Collins’ August 2018 statement.

Emory, like other universities in the U.S., is working closely with the NIH to address these concerns and to respond to NIH requests regarding specific projects. Through an internal investigation prompted by a letter that the NIH sent to many academic research universities, Emory discovered that two of its faculty members named as key personnel on NIH grant awards to Emory University had failed to fully disclose foreign sources of research funding and the extent of their work for research institutions and universities in China. Emory has shared this information with the NIH, and the faculty members are no longer employed at Emory.

It is important to note that Emory remains committed to the free exchange of ideas and research and to our vital collaborations with researchers from around the world. At the same time, Emory also takes very seriously its obligation to be a good steward of federal research dollars and to ensure compliance with all funding disclosure and other requirements.“

這份聲明在最后聲稱Emory信奉所謂思想自由碰撞、堅持國際科研合作，但就雙開兩位中國教授而言，絲毫看不出Emory校方學術自由的影子，政治干預和偽善的意味非常濃厚，自相矛盾的地方比比皆是。這從以下幾點可以看出：

首先，美國大學Tenure制度的起源，是為保障教授的學術自由，能在不受外界環境干預的影響下自由研究。Tenured的教授可以Fired for cause, 但是當事人的due process必須保障，包括procedure due process，無論是在大學內部，還是在美國的司法體系。事實上，這是美國的立國之本，是美國憲法第五修正案和第十四修正案所確認的。Emory 大學雙開兩位教授而沒有給予當事人任何辯解的機會和上訴渠道，既侵犯了兩位教授的學術自由，也侵犯了兩位教授應當享受的due process。

更嚴重的是，李曉江李世華實驗室多名中國學生也被一同解雇，并限30天內離境。即便教授有問題，為什么學生也要受到牽連？每一個學生究竟犯了什么錯，不需要一一核實嗎？就是因為他們都來自中國？說好的不因國籍、人種、膚色、各種各樣性取向性認知而受歧視呢？原來所謂Equal Protection只是精英階層拿溫室里面的弱勢群體當道具用的！

同樣滑稽的是，Emory今天甩鍋的時候，聲稱不知道李曉江海外經費來源及中國研究范圍，拿Credit的時候，可是毫不含糊。就在2018年3月29日，Emory官網還發布新聞，歌頌李曉江的研究成果。雖然他的主頁已經被刪，這篇新聞卻還掛在那里，有圖有真相，報道的是李曉江CRISPR-Cas9基因編輯亨廷頓疾病豬模型的重大突破，發表于Cell。看看新聞怎么說吧，這項研究得到美國NIH，中國重點研發計劃、基金委，和廣東省的資助！Emory能說不知道么？

The pig model of HD was established by researchers at Emory University School of Medicine, together with colleagues at Jinan University and Chinese Academy of Sciences in Guangzhou.

The research was supported by the U.S. National Institute of Neurological Disorders and Stroke (NS101701, NS095279, NS095181), National Key Research and Development Program of China (Stem Cell and Translational Research), the National Natural Science Foundation of China, and Guangdong Province.

最可笑的是，NIH院長Francis Collins 2017年6月27日，還在他的院長專欄里面，歌頌李曉江的研究成果，也是有圖有真相，怎么說的呢？

The progress, reported in the Journal of Clinical Investigation [1], comes from the NIH-supported team of Su Yang, Renbao Chang, Xiao-Jiang Li, and colleagues at Emory University School of Medicine, Atlanta. The group’s previous work showed that halting the production of mutated (or even healthy!) HTT protein in mature neurons doesn’t hurt the cells or cause obvious neurological problems in mice [2]

Collins院長治學嚴謹，專欄里面引用了兩篇李曉江的文章，大家自己看看PubMed里面顯示的這兩篇文章所列李曉江的兩個工作單位吧，到底有沒有披露，Collins院長不知道么？

見過無恥的，沒見過這么無恥的。真是斯文掃地、謊話連篇！